Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-20

Clinical Trial Update: Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether diabetes control influences treatment of diabetic macular edema with ranibizumab; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: Prof. Dr. Antonia M. Joussen | Conditions: Visual Acuity Reduced Transiently, Macular Edema, Cystoid | Phase 4 | Status: TERMINATED | Results posted: 2019-11-20